News and Events

Latest News

Mobidiag Secures Additional €4 Million in Capital Increase with Springvest´s Public Financing Round

Published on 24 May 2018

Mobidiag  has successfully completed a 4 million euros funding supported by the Finnish investment service company Springvest Oy (former Kansalaisrahoitus) for its global business development, including its capacity to answer growing needs for the new Novodiag® solution.


Read More




NEW! Amplidiag® CarbaR+MCR, a multiplex qPCR test for detection of antibiotic resistant bacteria

Published on 19 Apr 2018

CE-IVD marking of Amplidiag® CarbaR+MCR, a molecular test allowing detection of the main carbapenemase-producing organisms and colistin resistance markers in one single test.


Read More




Launch of Novodiag® Bacterial GE+, a new diagnostic test for on-demand detection of bacterial pathogens

Published on 17 Apr 2018

New molecular diagnostic test for the simultaneous detection of most common enteric pathogens directly from stool samples.


Read More